Policy catalysts

Policy catalysts and events, newest first.

DateCardAvg 5d

2026-09-13Liquidia Surpasses 5,000 Yutrepia Patients Amid United Therapeutics Patent SuitLQDA UTHR
2026-09-13Centene Targets Medicare Advantage Breakeven After Q2 Benefit Ratio Hits 89.5%CNC UNH-1.27%
2026-09-13Philippine cybercrime agency vows stronger ASEAN cooperation on online child safetyPHI PSEI
2026-09-12BRICS summit endorses a counter-terrorism action plan and tighter FATF alignmentEMB KRE USD+0.33%
2026-09-12BRICS leaders adopt New Delhi Declaration backing wider use of local currencies and cooperationCNH CNY-0.96%
2026-09-12Liquidia crosses 5,000 Yutrepia patients amid United Therapeutics patent fightUTHR
2026-09-12FDA approves Scholar Rock's Isembyld as first muscle-targeted SMA therapySRRK
2026-09-12HSBC winds down German transaction services as part of $2B cost programHSBC
2026-09-12Liquidia reaches 5,000 Yutrepia patients as United Therapeutics litigation weighsLQDA UTHR
2026-09-12FDA Approves Scholar Rock's Isembyld for Spinal Muscular AtrophySRRK
2026-09-12Liquidia Logs 5,000 Yutrepia Patients Amid Ongoing Litigation with UTHRLQDA UTHR
2026-09-12FDA approves Scholar Rock's Isembyld as first muscle-targeted therapy for SMASRRK
2026-09-12FDA approves Scholar Rock's Isembyld as first muscle-targeted therapy for SMASRRK
2026-09-12Liquidia Surpasses 5,000 Yutrepia Patients as United Therapeutics Patent Litigation LingersLQDA UTHR
2026-09-12Centene Medicare Advantage HBR Improves to 89.5% in Q2CNC UNH-1.27%
2026-09-12FDA Approves Scholar Rock's Isembyld as First Muscle-Targeted Therapy for SMASRRK
2026-09-12FDA Approves Scholar Rock's Isembyld for Spinal Muscular AtrophySRRK
2026-09-12Liquidia reaches 5,000 Yutrepia patients amid United Therapeutics patent litigationLQDA UTHR
2026-09-12Liquidia crosses 5,000 Yutrepia patients amid United Therapeutics patent fightLQDA UTHR
2026-09-12Eli Lilly immunology revenue rises 9% in H1 2026 to $2.6B on DICE and Morphic M&ALLY
2026-09-12FDA approves Scholar Rock's Isembyld for spinal muscular atrophySRRK
2026-09-12HSBC Winds Down German Transaction Services in $2B Cost DriveHSBC
2026-09-12FDA Approves Scholar Rock's Isembyld for Spinal Muscular AtrophySRRK
2026-09-12FDA approves Scholar Rock's Isembyld as first muscle-targeted SMA therapySRRK
2026-09-12Liquidia Surpasses 5,000 Yutrepia Patients as United Therapeutics Patent Battle PersistsLQDA UTHR
2026-09-12FDA Approves Isembyld for Spinal Muscular AtrophySRRK
2026-09-12Liquidia surpasses 5,000 Yutrepia patients as United Therapeutics litigation loomsLQDA UTHR
2026-09-12Liquidia Surpasses 5,000 Yutrepia Patients as United Therapeutics Litigation ContinuesLQDA UTHR
2026-09-12FDA approves Scholar Rock's Isembyld as first muscle-targeted SMA therapySRRK
2026-09-12FDA Approves Scholar Rock's Isembyld for Spinal Muscular AtrophySRRK
2026-09-11Leidos Moves Hypersonic Weapon Programs Into Production Phase Across Glide Body LinesLDOS LMT+1.75%
2026-09-11Israel and Lebanon postpone Rome talks on border issues until OctoberLBP LEB
2026-09-11FIFA announces the inaugural ASEAN Cup will be staged in Indonesia and Hong KongGOTO IDR JCI-7.38%
2026-09-11South Korea launches rapid-blocking system across financial sector to curb online fraud024110.KS KRW
2026-09-11Dubai's ruler appoints Abdalla Ahmed Mohamed Alrais Al Hammadi as CEO of settlement and enforcementDXB UAE+0.20%
2026-09-11Ukraine and Canada sign a 100-year partnership agreement in CalgaryCAD/UAH UKRAINE SOVEREIGN BONDS
2026-09-11Hong Kong firms are reported to be expanding tech links with Shenzhen0388.HK 0700.HK
2026-09-11European Commission transmits EU-India trade deal to member states for ratificationDAX SX5E-1.88%
2026-09-11Hong Kong remains exposed as AI-led regional capital flows and supply-chain realignment gather paceHKD HSI
2026-09-11FIFA announces Jakarta and Bandung will host the inaugural ASEAN CupIDR IHSG-7.38%
2026-09-11European Commission transmits EU-India trade deal to member states for ratificationDAX EURINR SX5E-1.88%
2026-09-11European Commission sets new strategic vision and regulatory package for outermost regionsEU FISHERIES EXPOSURE
2026-09-11Vertiv Announces $1.45B Acquisition of Utility Innovation HoldingsVRT
2026-09-11Leidos Moves Hypersonic Weapon Programs Into Production Phase Across Glide Body LinesLDOS LMT+1.75%
2026-09-11American Water Works Wins $68M New Jersey Rate Increase ApprovalAWK
2026-09-11American Water Works Secures $68M New Jersey Rate Increase for Capex PlanAWK WTRG
2026-09-11Leidos Moves Hypersonic Glide Body and Shield Programs into ProductionLDOS LMT+1.75%
2026-09-11Leidos Moves Hypersonic Weapon Programs Into Production Phase Across Glide Body LinesLDOS LMT+1.75%
2026-09-11American Water Works Secures $68M New Jersey Rate Increase for Capex PlanAWK WTRG
2026-09-11NextEra and Dominion Progress on Combination Following Shareholder ApprovalD NEE

See today's live cards

Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

Open Desk — $399/month